bronchitis%20-%20chronic%20in%20acute%20exacerbation
BRONCHITIS - CHRONIC IN ACUTE EXACERBATION

Chronic bronchitis is an infection of the trachea and bronchi for at least 3 consecutive months for more than 2 consecutive years.
The patient experiences symptoms of increase in dyspnea, sputum volume and sputum purulence over baseline on most days.

Diagnosis is basically based on clinical presentation.

Bronchitis%20-%20chronic%20in%20acute%20exacerbation Management

Prevention

Influenza Vaccine

  • The use of an annual influenza vaccine for all patients with chronic bronchitis is strongly recommended
    • Patients with chronic lung disease have a higher risk of complications from influenza infection
    • Annual influenza vaccination decreases the morbidity and mortality of influenza in the elderly by 50%
  • Please see Influenza disease management chart for further information

Pneumococcal Vaccine

  • It is recommended that pneumococcal vaccine be administered at least once to patients with chronic bronchitis
    • Consider repeating vaccine every 5-10 years in high-risk patients
  • Pneumococcal vaccine is safe and may reduce invasive pneumococcal infection in patients with COPD
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
21 Nov 2020
Ivermectin confers benefits in the treatment of COVID-19, with a recent study showing that its use helps reduce the risk of death especially in patients with severe pulmonary involvement.
Elvira Manzano, 12 May 2020
After months of work disruption, profound worrying, social distancing, and isolation, SARS-CoV-2* still rages on, unyielding to human interventions.
Rachel Soon, 05 Dec 2020

The Malaysian National Immunisation Programme (NIP) will now include a hexavalent combination DTaP-IPV-HiB-HepB vaccine and a pneumococcal vaccine.

Roshini Claire Anthony, 18 Jun 2020

Endorsement of unproven COVID-19 treatments by high-profile public figures led to a drastic increase in the search and purchase of said treatments in the US, according to a research letter published in JAMA.